Clinically-proven, topical silicone gel for the management and prevention of old and new scars. It is self-drying and forms a bond with the outer layer of skin cells to form a flexible, breathable, waterproof barrier, providing hydration and protection to the scar. This creates an environment which allows the scar to mature through normalised collagen synthesis cycles and improves the physiological and cosmetic appearance of the scar. Kelo-cote is available with additional UV SPF 30 for areas that require additional protection, such as face, neck and hands, and a spray, ideal for joints, flexures, hairy areas or sensitive scars such as those caused from burns.

Contains nystatin, hydrocortisone, dimeticone and benzalkonium chloride.

Non-steroidal cream designed to relieve the symptoms and signs of eczema (atopic dermatitis), allergic dermatitis (contact dermatitis) and psoriasis. Contains sodium hyaluronate, vitis vinifera seed extract and shea butter, which, when combined, forms an occlusive barrier; attracts moisture to the skin to help restore the skins natural barrier; and has an antioxidant action to help protect the skin barrier.

A 3-in-1, all‐purpose emollient, bath additive and soap substitute, which contains no fragrances, colourings, additives or preservatives and is suitable for all ages.

Formulation containing sodium pyrrolidone carboxylate 2.5%, a powerful humectant that helps to restore the skin’s natural hydrating properties.

Smooth-textured, unperfumed, white-to-off-white cream, containing 10% w/w urea in white soft paraffin.

An emollient bath additive and soap substitute, with light liquid paraffin 37.8% and isopropyl myristate 13%, that contains no known sensitizers.

Apremilast, an oral small-molecule inhibitor of phosphodiesterase 4 (PDE4), works intracellularly to modulate a network of pro-inflammatory and anti-inflammatory mediators. PDE4 is a cyclic adenosine monophosphate (cAMP)-specific PDE and the dominant PDE in inflammatory cells. PDE4 inhibition elevates intracellular cAMP levels, which in turn down-regulates the inflammatory response by modulating the expression of TNF-α, IL-23, IL-17 and other inflammatory cytokines.

Biosimilar of adalimumab (Humira).

Calcipotriol 50 micrograms/ml. Calcipotriol is a vitamin D derivative. In vitro data show that calcipotriol induces differentiation and suppresses proliferation of keratinocytes. The effect of calcipotriol in psoriasis is ascribed mainly to this.